The combination of the Canadian Light Source (CLS) synchrotron's unique biomedical imaging and therapy (BMIT) beamline and the vision of a multi-discipline researcher from the University of Saskatchewan in confirming fiction ...
Sep 14, 2017
0
2
(HealthDay)—A blend of brain circuits are altered in people who stutter, new research indicates.
Dec 5, 2016
0
3
A new proof of concept study has shown that an imaging technique more commonly used to assess cancer patients may also be of help in assessing disease and treatment effects in patients with inflammatory diseases. The study ...
Nov 30, 2016
0
1
Researchers Robiël Naziroglu and Frans Vos have developed a method for improving the assessment of MRI images in cases of Crohn's disease. In time, this may well enable more targeted monitoring and treatment of this chronic ...
Nov 21, 2016
0
1
Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients.
Nov 14, 2016
0
0
An ongoing challenge for scientists working to understand the brain is being able to see all its parts. Researchers have spent centuries developing better imaging techniques to see beyond the abilities of our naked eyes. ...
Oct 31, 2016
0
29
Serotonin is a neurotransmitter that's partly responsible for feelings of happiness and for mood regulation in humans. This makes it a common target for antidepressants, which block serotonin from being reabsorbed by neurons ...
Oct 20, 2016
0
86
Neuroscientist Anne Hafkemeijer is able to distinguish two different forms of dementia using advanced imaging techniques. This is the first step towards early recognition of dementia in patients on the basis of brain networks.
May 25, 2016
0
4
Much like electricity traveling down wires, nerve impulses in our brain travel along nerve fibers. And just as wires need insulation to function well, nerve fibers, too, rely on a kind of insulation called myelin, a fatty ...
May 5, 2016
0
51
New data presented today at The International Liver Congress 2016 in Barcelona, Spain, demonstrates that the drug sitagliptin - more commonly used to treat diabetes - was no more effective than placebo for reducing non-alcoholic ...
Apr 16, 2016
0
4
